CANY
VTRS icon

Caxton Associates (New York)’s Viatris VTRS Stock Holding History

Caxton Associates (New York)’s Portfolio VTRS Stock Details VTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-220,820
Closed -$2.56M – 688
2024
Q3 		$2.56M Hold
220,820
– – 0.1% 88
2024
Q2 		$2.35M Buy
+220,820
New +$2.44M 0.08% 130
2022
Q4 		– Sell
-60,596
Closed -$516K – 626
2022
Q3 		$516K Sell
60,596
-20,421
-25% -$201K 0.07% 231
2022
Q2 		$848K Buy
+81,017
New +$888K 0.08% 155
2018
Q4 		– Sell
-6,759
Closed -$247K – 480
2018
Q3 		$247K Buy
+6,759
New +$254K 0.02% 351
2013
Q4 		– Sell
-200,000
Closed -$7.63M – 278
2013
Q3 		$7.63M Buy
+200,000
New +$7.04M 0.4% 64

Other funds holding VTRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Caxton Associates (New York)'s VTRS Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Viatris (VTRS) in Q4 2024, closing a stake of 220,820 shares — an estimated $2.56M sold.

Caxton Associates (New York) first reported a position in VTRS in Q3 2013 and held it in 6 quarters. The position peaked at $7.63M in Q3 2013. 1,040 funds tracked by Wall St. Rank hold VTRS as of Q4 2024.

  • Caxton Associates (New York) reported no remaining Viatris position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 220,820 Viatris shares in Q4 2024, an estimated $2.56M.
  • Caxton Associates (New York) first reported a position in Viatris in Q3 2013 and held it in 6 quarters.
  • Caxton Associates (New York)'s Viatris position peaked at $7.63M in Q3 2013.
  • 1,040 funds tracked by Wall St. Rank held Viatris as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.